Please login to the form below

Not currently logged in
Email:
Password:

Dr Stephen Hoffman joins Bicycle Therapeutics

He becomes chairman of the board

Cambridge, UK-headquartered Bicycle Therapeutics has named Dr Stephen Hoffman as chairman of its board of directors.

Dr Hoffman brings 30 years of experience in the pharmaceutical and financial industries to the biotech, currently serving as a senior advisor to PDL BioPharma and president of 10x Capital, an investment management firm.

He is also a member of the board of directors of AcelRx Pharmaceuticals, Dicerna Pharmaceuticals and Genocea Biosciences.

Previously, Dr Hoffman was managing director at Skyline Ventures from 2005 to 2014, and served as president, chairman, chief executive officer and director of Allos Therapeutics between 1994 and 2012.

Kevin Lee, chief executive of Bicycle Therapeutics, said: “Stephen has significant global healthcare experience and a strong track record of creating new medicines to address important unmet patient needs across a range of diseases, including oncology.

“We are pleased to welcome Stephen as our board chairman, and believe his experience founding, building and advising biotechnology companies will be instrumental in guiding the company as we develop innovative new cancer medicines and further advance our proprietary platform.” 

21st July 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics